MAM
MSL appoints Shashanka Nanda as vice president North & West of 20:20 MSL
MUMBAI: MSL, Publicis Groupe’s exclusive strategic communications firm, Monday announced the appointment of Shashanka Nanda as vice president, north and west at 20:20 MSL, based in Delhi NCR. With over two decades of experience, Nanda brings deep knowledge of integrated communications, leading multi-stakeholder campaigns across verticals including technology, automotive, aviation, and infrastructure across public and private sectors. Prior to this appointment, he held the position of vice president and technology lead at Edelman, India.
MSL South Asia CEO Amit Misra said, “Shashanka is an accomplished professional. His depth of experience will add strategic value across our diverse client portfolio. As a strategic thinker and team player, his knowledge of the communication environment will be complementary to our operations. I am confident that he will be a great asset to our teams and I look forward to working closely with him.”
“We are delighted to have Shashanka join our team,” said 20:20 MSL MD Viju George. “With his deep expertise in the technology sector, he will be a terrific addition to our leadership team as we continue to focus on expanding our bouquet of services and up-scaling our offerings.”
During the course of his career, Nanda has advised global corporations, start-ups, not for profits and governments on developing and executing effective communication strategies. A few clients that he has managed include organizations such as Microsoft, HP, TrendMicro, Oracle, Hitachi Data Systems, Airbus, GMR, Maruti Suzuki, the ministry of renewable energy, government of India, the government of Rajasthan and Madhya Pradesh, and the World Bank, among others.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
